Study: Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies
14 May, 2019 | 05:58h | UTCEstimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies: A Cost-effectiveness Analysis – JAMA Internal Medicine (free for a limited period)
Invited Commentary: Screening Options for Preventing Cervical Cancer (free for a limited period)
Author Interview: Estimated Quality of Life and Economic Outcomes Associated With Cervical Cancer Screening (free audio)
“Cytologic testing every 3 years and low-cost high-risk human papillomavirus testing every 5 years both may be considered reasonable cervical cancer screening options.”
Related Commentary on Twitter
Cytology every 3 years and low-cost #hrHPV testing every 5 years are both reasonable cervical-cancer screening options for women ages 30-65. https://t.co/yRCzmKGxP9
— JAMA Internal Medicine (@JAMAInternalMed) May 13, 2019